| ²é¿´: 1340 | »Ø¸´: 9 | |||
| ¡¾Óн±½»Á÷¡¿»ý¼«»Ø¸´±¾Ìû×Ó£¬²ÎÓë½»Á÷£¬¾ÍÓлú»á·ÖµÃ×÷Õß runner_stu µÄ 2 ¸ö½ð±Ò £¬»ØÌû¾ÍÁ¢¼´»ñµÃ 1 ¸ö½ð±Ò£¬Ã¿ÈËÓÐ 1 ´Î»ú»á | |||
[½»Á÷]
ÎÄÕ¼øÉÍ£ºUfSP2µ÷¿ØDNAËðÉËÐÞ¸´µÄ»úÖÆ
|
|||
|
ÎÄÕ¼øÉÍ£ºDynamic recruitment of UFM1-specific peptidase 2 to the DNA double-strand breaks regulated by WIP1 ÈËÌåϸ°ûÿÌìÔâÊܵÄDNAËðÉ˸ߴï100000´ÎÒÔÉÏ£¬Ó°ÏìÒòËØ°üÀ¨ÄÚÔ´ÐÔÒòËØ£¨±ÈÈçÈËÌå´úлÎïÑõ»¯×ÔÓÉ»ù£©ºÍÍâÔ´ÐԴ̼¤£¨×ÏÍâÏßÕÕÉä¡¢µçÀë·øÉä¡¢»·¾³ÎÛȾ¼°»¯Ñ§¶¾ËØ£©¡£DNAË«Á´¶ÏÁÑ£¨DSB£©ÊÇ×îÖÂÃüµÄDNAËðÉËÀàÐÍ£¬Ò»µ©·¢ÉúDSB£¬¶¥¶Ë¼¤Ã¸ATM½«¿ìËÙ¼¤»î²¢Ñ¸ËÙÆô¶¯DNAËðÉË·´Ó¦ÐźÅ[1-2]¡£ ATM¼¤»îÊܵ½¶àÖÖ·ÒëºóÐÞÊεĹ²Í¬µ÷½Ú£¬Èç·ºËØ»¯¡¢Á×Ëữ¡¢ÒÒõ£»¯ºÍ¼×»ù»¯µÈµÈ¡£UFMõ£»¯Á¬½ÓøUFM1ÌØÒìÐÔëÄø2£¨UfSP2£©ÊÇÒ»ÀàÈ¥³ýUFM1õ£»¯µÄø£¬´ËǰÒÑÓб¨µÀUfSP2Äܹ»ÒÖÖÆATM¼¤»î£¬µ«UfSP2ÈçºÎµ÷½ÚDNAËðÉË·´Ó¦µÄ»úÖÆÈÔδÇå³þ[3-4]¡£À´×ÔÃÀ¹ú÷°ÂҽѧÖÐÐĵÄÂ¥ÕñÀ¤ÍŶӽüÆÚÔÚSample Text ÔÓÖ¾ÉÏ·¢±íÁËÌâΪ¡°Dynamic recruitment of UFM1-specific peptidase 2 to the DNA double-strand breaks regulated by WIP1 ¡±µÄÑо¿ÂÛÎÄ£¬½ÒʾÁËUfSP2ÈçºÎ¾«È·µ÷¿ØATMͨ·½ø¶øÓ°ÏìDNAËðÉËÐÞ¸´½ø³Ì¡£ [swf]https://641331.freep.cn/641331/fig%201.png[/swf] Fig. 1 UfSP2 suppresses ATM activation. ×÷ÕßÊ×ÏÈÓÃUfSP2ÇóýµÄ293Tϸ°ûת¼»ØÒ°ÉúÐ͵ÄUfSP2»ò²»´øÈ¥¼×õ£Ã¸»îÐÔµÄUfSP2£¬·øÉäÌõ¼þϼì²âÁËATM±í´ï¼°ÆäÁ×Ëữˮƽ£¬ÑéÖ¤ÁËUfSP2È¥Á×ËữH4²¢ÒÖÖÆATM¼¤»î£¨Fig. 1£© [swf]https://641331.freep.cn/641331/fig%202.png[/swf] Fig. 2 Recruitment of UfSP2 to DSB is later than UFL1 recruitment following IR. ÀûÓÃÃâÒß¹²Ó«¹âµÄ·½·¨, ×÷Õß¼ì²âÁËUFL1ºÍUfSP2µÄ¶¯Ì¬·Ö²¼£¬½á¹ûÏÔʾ£¬ºÍUFL1Ïà±È£¬UfSP2ÒÔ½ÏÂýµÄ¶¯Á¦Ñ§ÕÐļµ½DSB£¬²¢ÔÚDSB´¦È¥³ýUFM1 (Fig. 2)¡£µ«UfSP2ÈçºÎ±»ÕÐļµ½DSB£¬ÈÔÊÇδ֪£¬Òò´Ë×÷ÕßɸѡÁËDNAËðÉË·´Ó¦ÖеÄDZÔÚÏ໥×÷Óõ°°×£¬·¢ÏÖUfSP2¿ÉÒÔÓëMre11Ï໥×÷Óã¨Fig. 3a£©¡£Í¨¹ý¶¯Ì¬¼à²â£¬ËûÃÇ·¢ÏÖUfSP2ÔÚIRºóÁ¢¼´´ÓMRN½âÀ룬µ±ATM¼¤»î¹ý³ÌÍê³Éʱ£¬ÆäÓëMRN¸´ºÏÎïµÄÏ໥×÷ÓÃÔÚIRºó2СʱÔòÖð½¥»Ö¸´£¨Fig. 3a£©£¬ MRE11µÄȱʧÔò»áÓ°ÏìUfSP2²¡ÔîµÄÐγɣ¨Fig. 3b£¬c£©£¬ÕâЩ½á¹û±íÃ÷£¬UfSP2ÊÇÓÉMRN¸´ºÏÌåÕÐļµ½DNAË«Á´¶ÏÁѲ¿Î»µÄ¡£ [swf]https://641331.freep.cn/641331/fig%202.png[/swf] Fig. 3 The interaction of UfSP2 with the MRN complex is regulated by ATM-mediated phosphorylation. ATMÊÇDSBÓÕµ¼µÄDNAËðÉË·´Ó¦ÖÐÖØÒªµÄÉÏÓμ¤Ã¸£¬Í¨¹ý·ÖÎöUfSP2µÄµ°°×ÖÊÐòÁкÍWB·½·¨£¬×÷Õß·¢ÏÖATMµ÷½ÚUfSP2µÄÁ×Ëữ²¢Ó°ÏìÆäÓëMRNµÄ½áºÏ£¬Í¨¹ýÃâÒß¹²³ÁµíµÄ·½·¨£¬È·¶¨ÁËUfSP2µÄÈ¥Á×ËữÊܵ½Wip1µ÷¿Ø£¨Fig. 4£©¡£ [swf]https://641331.freep.cn/641331/fig%204.png[/swf] Fig. 4 The phosphatase WIP1 removes phospho-group from UfSP2 induced by ATM. DNAË«Á´¶ÏÁѵÄËðÉËÐÞ¸´»úÖÆÒÑÓдóÁ¿µÄ±¨µÀ£¬ ATMÊÇÒÑÖªµÄ×îΪ¹Ø¼üµÄÉÏÓμ¤Ã¸¡£±¾ÎÄ×÷Õßͨ¹ýһϵÁеÄʵÑ飬Ìá³öÁËUfSP2¶ÔATM¼¤»îµÄ΢Ãµ÷ÖÆ»úÖÆ£ºÕý³£Çé¿öÏ£¬UfSP2ÓëMRN¸´ºÏÎï½áºÏ£¬Ò»µ©·¢ÉúDSB£¬ATMѸËÙ¼¤»î²¢ÓÕµ¼UfSP2Á×Ëữ£¬µ¼ÖÂUfSP2´ÓMRN¸´ºÏÎïÍÑÂ䣬DNAËðÉËÐÞ¸´³ÌÐòÆô¶¯£»µ±ATM¼¤»î¹ý³ÌÍê³Éʱ£¬UfSP2ÔÚWip1µ÷¿ØÏÂÈ¥Á×Ëữ£¬²¢ÔÚMRNÕÐļÏ»ºÂýÖØÐ½áºÏµ½DSB²¿Î»£¬ÒÖÖÆATMµÄ¹ý¶È¼¤»îÒÔ·Àֹϸ°ûµòÍö£¬´Ó¶ø±£Ö¤ÁËϸ°û¼ÈÄÜ¿ìËÙÐÞ¸´DNAË«Á´¶ÏÁÑÓÖ²»»á·¢Éú¹ý¶ÈÐÞ¸´¡£¸Ã·¢ÏÖÊ״βûÃ÷ÁËUfSP2²ÎÓëDSBÐÞ¸´µÄ×÷ÓûúÖÆ£¬¶ÔATMͨ·×ö³öÁËÖØÒªµÄÐÞÕý¡£ ÎÄÕÂͨѶ×÷ÕßÂ¥ÕñÀ¤½ÌÊÚÀ´×ÔÃÀ¹úµÄ÷°ÂҽѧÖÐÐÄ£¬³¤ÆÚÖÂÁ¦ÓÚDNAËðÉËÐÞ¸´Ñо¿£¨³¤°´Ï·½Í¼Æ¬É¨Âë¿É·ÃÎÊ×÷ÕßÖ÷Ò³£©¡£ [swf]https://641331.freep.cn/641331/fig%205.jpg[/swf] ¹ØÓÚGenome Instability & Disease£º Genome Instability & Disease £¨GIAD£©ÊÇÉîÛÚ´óѧҽѧ²¿ÓëÒâ´óÀûÃ×À¼·Ö×ÓÖ×ÁöÑо¿Ëù (IFOM) µÄÓ¢ÎĹٷ½³ö°æÎÓÉSpringer Nature ¼¯Íųö°æ ( ISSN: 2524-7662 ) ¡£ÔÓÖ¾Ö÷Òª·¢±í»ùÒò×éÎȶ¨ÐÔά³Ö»úÖÆ¼°ÆäÏà¹ØÈËÀ༲²¡µÄ·Ö×Ó»úÖÆºÍÖÎÁÆÓ¦ÓõĸßÖÊÁ¿¡¢Í¬ÐÐÆÀÉóµÄÔ´´Ñо¿ÂÛÎÄ¡¢×ÛÊö¡¢¼ò¶ÌͨÐÅ¡¢ÊµÑé·½°¸ºÍÆÀÂÛÎÄÕ¡£ÆÚ¿¯Ä¿Ç°¹²Óбàί51Ãû£¬°üÀ¨5ÃûԺʿºÍ5Ãû»áÊ¿£¬19Ãû¹ú¼Ê±àί£¬¾ùÀ´×ÔDNAËðÉËÐÞ¸´ÁìÓòµÄÖªÃû¿ÆÑ§¼Ò¡£Ö÷±àÊÇÉîÛÚ´óѧµÄÖìÎÀ¹ú½ÌÊÚºÍÒâ´óÀûIFOMµÄMarco Foiani½ÌÊÚ¡£ ×Ô2020ÄêÕýʽ´´¿¯ÒÔÀ´£¬GIADÒÑÁ¬Ðø³ö°æ18ÆÚ£¬Æ½¾ùƪÏÂÔØÁ¿³¬¹ý1200´Î£¬±»CNKI¡¢Google Scholar µÈ¶à¸öÊý¾Ý¿âÊÕ¼£¬²¿·ÖÎÄÕÂÒѱ»PubMedºÍSCIÊÕ¼¡£ [swf]https://641331.freep.cn/641331/%E5%8C%BB%E5%AD%A6%E9%83%A8%E7%A7%91%E7%A0%94%E5%8A%9E%20%E5%AF%B9%E6%8A%98%E9%A1%B5%20a3%20250%E9%93%9C%E7%89%88%E7%BA%B8%E5%8F%8C%E9%9D%A2%E5%BD%A9%E8%89%B2%20%E5%8E%8B%E7%97%95%E5%AF%B9%E6%8A%98%20100%E4%BB%BD_%E9%A1%B5%E9%9D%A2_2.jpg[/swf] ÆÚ¿¯±àίÍÅ¶Ó https://641331.freep.cn/641331/% ... 1%B5%E9%9D%A2_1.jpg ÆÚ¿¯Òѱ»ÊÕ¼µÄÊý¾Ý¿â [swf]https://641331.freep.cn/641331/7326471523911432953-115.jpg[/swf] ×÷Ϊп¯£¬²¿·ÖÎÄÕÂÒѱ»PubmedÊÕ¼ Genome Instability & Disease Ö÷Òª·¢±íÒÔÏÂÁìÓòµÄÎÄÕ£º Topics may include, but are not limited to: Ø Cell cycle checkpoints Ø DNA damage response Ø Post-translational modifications Ø Epigenetic regulation Ø Radio/chemotherapeutic sensitization Ø Genome stability genes as a therapeutic target Ø Genome instability-associated diseases Ø Neurodegenerative diseases Ø DNA damage-based therapy and drug discovery ²Î¿¼ÎÄÏ×£º 1. Lavin, M. F. (2008). Ataxia-telangiectasia: From a rare disorder to a paradigm for cell signalling and cancer. Nature Reviews Molecular Cell Biology, 9, 759¨C769. 2. Lee, J. H., & Paull, T. T. (2004). Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science, 304, 93¨C96. 3. Qin, B., Yu, J., Nowsheen, S., Wang, M., Tu, X., Liu, T., Li, H., Wang, L., & Lou, Z. (2019). UFL1 promotes histone H4 ufmylation and ATM activation. Nature Communications, 10, 1242. 4. Wang, Z., Gong, Y., Peng, B., Shi, R., Fan, D., Zhao, H., Zhu, M., Zhang, H., Lou, Z., Zhou, J., Zhu, W. G., Cong, Y. S., & Xu, X. (2019). MRE11 UFMylation promotes ATM activation. Nucleic Acids Research, 47, 4124¨C4135. |
» ²ÂÄãϲ»¶
ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©
ÒѾÓÐ3È˻ظ´
Çóµ÷¼Á£ºÒ»Ö¾Ô¸£ºÄϾ©´óѧ רҵ£º0705 ×Ü·Ö320 £¬±¾¿Æ985£¬ËÄÁù¼¶Òѹý
ÒѾÓÐ3È˻ظ´
»·¾³¹¤³Ì 085701£¬267Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
308Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
Çóµ÷¼Á£º085600²ÄÁÏÓ뻯¹¤£¬¿¼²Ä¿Æ»ù£¬×Ü·Ö319
ÒѾÓÐ21È˻ظ´
311Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
294·Ö080500²ÄÁÏ¿ÆÑ§Ó빤³ÌÇóµ÷¼Á
ÒѾÓÐ13È˻ظ´
288Çóµ÷¼Á Ò»Ö¾Ô¸¹þ¹¤´ó ²ÄÁÏÓ뻯¹¤
ÒѾÓÐ19È˻ظ´
288×ÊÔ´Óë»·¾³×¨Ë¶Çóµ÷¼Á£¬²»ÏÞרҵ£¬ÓÐѧÉϾÍÐÐ
ÒѾÓÐ23È˻ظ´
Ò»Ö¾Ô¸085600ÖпÆÔºÄþ²¨Ëù276·ÖÇóµ÷¼Á
ÒѾÓÐ17È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
¡¾Ç¿ÍÆ£ü¿ÉÁôУ¡¿¼ÃÄÏ´óѧ²©Ê¿ºóÕÐÆ¸£¨Ë®Àû¹¤³Ì/ÌúÃÌ̼»·¾³¹ý³Ì£©
+1/279
Ìì½ò¿Æ¼¼´óѧÉúÎïÖʹ¦ÄܲÄÁÏÑо¿ÍÅ¶Ó Ë¶Ê¿ÕÐÉú
+1/87
¿¼Ñе÷¼Á!
+1/40
Î人¹¤³Ì´óѧ»¯»·Ñ§Ôº³ÌÀÏʦ¿ÎÌâ×éÕÐÊÕ»¯Ñ§Ààѧ˶¡¢»¯Ñ§¹¤³ÌÓë»·¾³¹¤³Ìר˶µ÷¼Á
+2/36
Ìì½ò¿Æ¼¼´óѧ-£¨ÔºÊ¿ÍŶӣ©ÏȽøÏËάÓëÖ½»ù¹¦ÄܲÄÁÏÍÅ¶Ó ÕÐÊÕ˶ʿÉú
+1/35
Î÷¾©Ñ§ÔºÍÁľˮÀû 2026 ¼¶Ñо¿ÉúÕÐÉú
+2/30
¿¼Ñе÷¼ÁÕÐÉú
+1/26
¼ªÁÖ¹¤³Ì¼¼Êõʦ·¶Ñ§Ôº ½»²æÑ§¿ÆÑо¿Ôº µ÷¼ÁÕÐÉú
+1/19
Ìì½òÀí¹¤´óѧ¹¦Äܾ§ÌåÑо¿Ôº£¨¾§Ìå²ÄÁÏÈ«¹úÖØµãʵÑéÊÒ£©½ÜÇàÍŶÓÕÐÊÕ2026Ä격ʿÑо¿Éú
+1/18
¹ã¶«¹¤Òµ´óѧ»úµç¹¤³ÌѧԺ¸ßΰ½ÌÊÚÕÐÊÕ²©Ê¿Éú
+1/15
ÕÐÊÕ»ù´¡Ò½Ñ§¡¢Ò½Ñ§¼¼Êõ¡¢Ò½Ñ§¼ìÑé¡¢¹«¹²ÎÀÉúÓëÔ¤·Àҽѧ¡¢Ò©Ñ§µÈרҵ˶ʿÑо¿Éúµ÷¼Á
+3/10
ÕÐÊÕ2026רҵ´úÂë08¿ªÍ·Ñ§ÊõÐÍ˶ʿÑо¿Éú
+1/9
»¶Ó¼ÓÈëÎÒÃǵÄÍŶӣ¡Õв©Ê¿ °ëµ¼Ìå¹âµç×ÓÆ÷¼þÓ뼯³É
+1/9
Î人¹¤³Ì´óѧ»¯Ñ§Óë»·¾³¹¤³ÌѧԺ 2026 Äê˶ʿÑо¿Éúµ÷¼Á¹«¸æ
+1/8
ɽ¶«Å©Òµ´óѧ»¯Ñ§Óë²ÄÁÏ¿ÆÑ§Ñ§Ôº 2026Äê˶ʿÑо¿ÉúÄâ½ÓÊÕµ÷¼Á
+1/8
º«¹úÇìÎõ´óѧ Yu Taekyung ½ÌÊÚÕÐ2026Ä격ʿÑо¿Éú
+1/7
ÈýÏ¿´óѧ²Ä»¯Ñ§ÔºÄÜÔ´»·±£¾§Ì¬²ÄÁÏ¿ÎÌâ×é½ÓÊÕµ÷¼Á£¬ÕÐÊÕ»¯Ñ§Àà˶ʿ
+1/7
¡¾ÉϺ£µ÷¼Á¡¿985ÁªºÏÅàÑø£¡±ð´í¹ýÄÜËÍÄãÈ¥½»´ó/ͬ¼Ã/ÖпÆÔºµÄÉñÏɵ¼Ê¦£¡
+1/6
271¹òÇóµ÷¼Á
+1/4
Çൺ´óѧ»¯Ñ§¹¤³Ì£¨085602£©Ó뻯ѧ¹¤³ÌÓë¼¼Êõ£¨081700£©ÕÐÊÕ´óÁ¿µ÷¼Á
+1/4
chenhuanlong
ר¼Ò¹ËÎÊ
¡ï
runner_stu(½ð±Ò+1): лл²ÎÓë
runner_stu(½ð±Ò+1): лл²ÎÓë
|
±¾ÌûÄÚÈݱ»ÆÁ±Î |
5Â¥2023-01-04 19:00:05
10Â¥2024-11-17 19:49:20
¼òµ¥»Ø¸´
tzynew2Â¥
2023-01-04 16:31
»Ø¸´
runner_stu(½ð±Ò+1): лл²ÎÓë
o ·¢×ÔСľ³æAndroid¿Í»§¶Ë
GZ8509053Â¥
2023-01-04 16:32
»Ø¸´
runner_stu(½ð±Ò+1): лл²ÎÓë
nono20094Â¥
2023-01-04 17:00
»Ø¸´
runner_stu(½ð±Ò+1): лл²ÎÓë
`
yuekong6Â¥
2023-01-04 19:10
»Ø¸´
bush2867Â¥
2023-01-04 20:48
»Ø¸´
runner_stu(½ð±Ò+1): лл²ÎÓë
¡£ ·¢×ÔСľ³æAndroid¿Í»§¶Ë
XG-WUST8Â¥
2023-01-05 07:00
»Ø¸´
runner_stu(½ð±Ò+1): лл²ÎÓë
up ·¢×ÔСľ³æIOS¿Í»§¶Ë
xiaoqiuqiu209Â¥
2023-01-05 22:03
»Ø¸´
runner_stu(½ð±Ò+1): лл²ÎÓë














»Ø¸´´ËÂ¥